Advertisement
Home »

PRL-mediated STAT5B/ARRB2 pathway promotes the progression of prostate cancer through the activation of MAPK signaling.

Feb 12, 2024

ABOUT THE EXPERTS

  • Tao Yang

    Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.

    Department of Urology, The Third People’s Hospital of Chengdu/The Affiliated Hospital of Southwest Jiaotong University, Chengdu, Sichuan, China.

    Yongnan Chi

    Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.

    Xin’an Wang

    Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.

    Chengdang Xu

    Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.

    Xi Chen

    Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.

    Ying Liu

    Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.

    Shengsong Huang

    Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.

    Xuyou Zhu

    Department of Pathology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.

    Haoyang Zhang

    Department of Pathology, Baoshan Branch, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

    Hui Zhuo

    Department of Urology, The Third People’s Hospital of Chengdu/The Affiliated Hospital of Southwest Jiaotong University, Chengdu, Sichuan, China. zhuoh9999@163.com.

    Denglong Wu

    Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China. wudenglong2009@tongji.edu.cn.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement